Single dose of zilebesiran linked to reduction in systolic BP
A single dose of subcutaneous zilebesiran is associated with a reduction in systolic blood pressure (SBP), according to a study published online Feb. 16 in the Journal of the American Medical Association.
Feb 20, 2024
0
1